Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Pricing for Oncology Biosimilars—Reply

In Reply I thank Drs Jensen and Tichy for the opportunity to respond to the comments on our article on hospital adoption and pricing for oncology biosimilars. Their comments are factually correct and add insight into the complex process of drug payment and strengthen the core message of our article.

We haven't written up this one. JAMA has the full story — the link below goes straight to it.

Read the original at jamanetwork.com →

More in Health & Medicine

More from Tuesday 28 July →